BC
Broadwood Capital Portfolio holdings
AUM
$1.53B
This Quarter Return
-4.28%
1 Year Return
+36.91%
3 Year Return
+67.63%
5 Year Return
+132.65%
10 Year Return
+697.91%
AUM
$1.33B
AUM Growth
+$1.33B
(-4.4%)
Cap. Flow
+$25.2M
Cap. Flow
% of AUM
1.9%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
BTRS
BTRS Holdings Inc. Class 1 Common Stock
BTRS
|
$19.8M |
| 2 |
IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
|
$5.4M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 51.82% |
| 2 | Consumer Staples | 32.54% |
| 3 | Industrials | 5.34% |
| 4 | Technology | 1.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
STAAR Surgical
STAA
$1.36B
| $609M | 45.94% |
8,592,007
| – | – |
|
2
Monster Beverage
MNST
$60.9B
| $432M | 32.54% |
4,656,488
| – | – |
|
3
iShares Russell 2000 ETF
IWM
$67B
| $117M | 8.81% |
690,000
| – | – |
|
4
Axon Enterprise
AXON
$58.7B
| $70.8M | 5.34% |
760,062
| – | – |
|
5
Lineage Cell Therapeutics
LCTX
$267M
| $55.2M | 4.16% |
34,935,485
| – | – |
|
|
IMDX
6
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $21M | 1.58% |
23,353,697
+6,003,752
| +35% | +$5.4M |
|
|
BTRS
7
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| $19.8M | 1.49% |
+3,977,701
| New | +$19.8M |
|
8
Serina Therapeutics
SER
$54.5M
| $1.73M | 0.13% |
2,997,156
| – | – |
|